echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Analysis of National Drug Purchase Contract Renewal: Classified and Implementing Policies to Stabilize the Market and Encourage Innovation

    Analysis of National Drug Purchase Contract Renewal: Classified and Implementing Policies to Stabilize the Market and Encourage Innovation

    • Last Update: 2021-11-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Author| Shandong Fengqing's
    recent national drug purchase renewal trend has been higher than that of each wave.
    How can one to three batches be continued in the local area? How to continue? There are all kinds of speculations in the industry, and most of them are some third-party agents trying to catch the wind
    .
    In fact, when looking at the contract renewal of Guocai, we can no longer use the conventional thinking of "continuing" and "renewing", otherwise it will only be smashed by the ruthless market
    .

    According to the "Opinions of the General Office of the State Council on Promoting the Normalized and Institutionalized Development of Drug Centralized and Volume Procurement" (Guobanfa [2021] No.
    2) and the recently issued "Leading Group for Deepening the Reform of the Medical and Health System of the State Council on Further Promoting Fujian Province Sanming City’s experience in deepening the implementation of the medical and health system reform "relevant policies", normalize, institutionalize, and standardize the state-organized centralized procurement of pharmaceuticals and consumables, gradually expand the scope of procurement, and strive to purchase more than 300 generic names for drugs by the end of 2022
    .
    At the end of the "14th Five-Year Plan" period, it has become an indisputable fact that the number of generic names for centralized procurement of drugs by national and provincial organizations in each province will exceed 500
    .

    From a comprehensive analysis point of view, the renewal products will continue to adhere to the "project system" for volume purchases, and the creation of a "project" itself contains various necessary elements, from the formulation and release of tenders, the combination of volume and price, and the guarantee of payment.
    , Quantity distribution, time performance and other aspects are indispensable
    .
    Therefore, friends in the industry have to think clearly that the renewal of Guocai's contract is not a simple renewal
    .


    The renewal methods of national sourcing are different in different regions, and the renewal rules of national sourcing need to be clarified .
    At present, the renewal methods of national sourcing varieties are still different in different regions: Hubei Province adopts the method of "inquiry before bidding", whether there are new ones or not.
    Inquiry on the over-evaluation situation, the introduction of unselected original research drugs takes the lowest price of the original selected price as the highest effective quotation, and the lowest price after the bidding is the newly selected company .
    An inter-provincial alliance organized by Guangdong carried out mass purchases of cephalexin, and all product specifications and dosage forms under the generic name were included .
    The cephalexin renewal rules in Hebei Province are presented in an exclusive way




    .
    The Beijing plan is not as simple as "dual selection" as some new media claim.
    The key element of Beijing Guocai's contract renewal is "linkage with quantity and two-way selection
    .
    " In the final analysis, it is still necessary to link the country and provinces (autonomous regions, municipalities) to purchase the selected price with volume, and then determine the selected product through mutual selection between the buyer and the seller
    .
    Therefore, the feature of Beijing's contract renewal plan is "volume and price linkage, and mutual selection between purchase and sale
    .
    " The rules for re-centralized procurement at the expiration date of Beijing are different from those of Shanghai, Hubei, and Guangdong.
    This difference is in terms of price limit, logic, and mode, rather than simply using a "dual selection" to explain the matter.

    .

    However, the "Notice" clearly requires that, in principle, all nationally-sourced drugs should continue to carry out centralized and volume procurement.
    It can be understood that the relevant parties do not encourage direct contract renewal.
    This discouragement is actually a shadow of classified procurement.
    Measures
    .
    Why are there still classified purchases of these connected varieties? This is actually a way to open the structure and subdivide the procurement
    .
    Just like the No.
    7 document of Guocai, bidding and purchasing are carried out for the varieties with a large amount and the amount of money, and the bargaining price for other varieties and the hanging of the net
    .
    The same logical concept is applied to the contract renewal of National Procurement.
    It can be understood that the varieties selected by the equal amount due to insufficient competition at that time can be understood as a price reduction.
    There is still room for price reduction.
    Under the new situation, it is understandable to use multiple competitions to bid for such varieties
    .
    For varieties with relatively sufficient competition, especially 6 and above, they can only be listed as "competitive varieties".
    There is still a certain distance from the "sufficiency of competition".
    The concept has undergone a whole new change
    .
    Based on this, on the basis of stabilizing prices, relevant parties are still inclined to comprehensive reviews
    .
    At the same time, it is particularly mentioned that the price of the last round of low prices and rising costs cannot continue to be supplied, and the price can rise appropriately.
    This is actually more like a rational market behavior.
    The price has indeed bottomed out and a callback can be allowed.
    After all, market competition, No one can see that there is no reasonable profit at a super low price
    .


    In addition to purchasing with quantity, the imagination about hanging the net

    Starting from the date when the country locks the catalog, generates new prices, and expires, how to carry out a new round of mass purchase of these varieties is the authority of each provincial medical insurance department
    .
    Divided into two, when the contract expires, the related varieties no longer have the attribute of mass procurement in principle.
    Like other newly reviewed and unreviewed varieties, they all have the opportunity to participate in classified procurement
    .
    It's just that the pearls and jade are in the front, and the dual status of "over-review + national mining" makes it difficult for provincial units to grasp the size
    .
    From this perspective, after the contract expires, what sort of procurement measures each province will take for related varieties is, in principle, a local matter
    .
    Therefore, this is why the national procurement renewal plan circulated in the industry in the early stage especially emphasized: "After the expiration of the national organization drug centralized procurement agreement, the province (or inter-provincial alliance) shall be used as the unit to carry out the renewal work
    .
    In principle.
    All national organizations should continue to carry out centralized procurement of drugs, not just bargaining, without quantity
    .
    "
    In fact, another way of thinking, is it possible to carry out regular online listing of varieties that have already undergone national


    procurement ? After all, the full contract has been completed, and clinical medication habits have become dependent on a certain degree.
    From the perspective of market development and commercial distribution, a relatively smooth channel has been opened.
    For these varieties with relatively stable prices and relatively mature supply and marketing systems, we have adopted The Internet approach, allowing medical institutions to float up and down bargaining prices may not be a new option .
    After all, Circular 2 also states: "After the expiration of the purchase agreement, we should focus on stabilizing market expectations, stabilizing price levels, and stabilizing clinical use, and comprehensively considering factors such as reliable quality, stable supply, good credit, and clinical demand .
    " How stable and how stable, the locality can still achieve new breakthroughs and innovations .


    "Small-class procurement" of the contract renewal of National Procurement: One category, one policy is the mainstream.
    From the perspective of a series of local operations of National Procurement’s contract renewal, the classified implementation of policies and the first category of one policy are still the overall guiding principles of National Procurement’s renewal varieties.
    Some prices need to be steady, some prices are allowed to be adjusted upwards, and some prices are as low as possible.



    .
    In short, the price competition method under the classification model is still dominated by the current market situation.
    If the market has a positive effect, it will continue to advance.
    If the market has a certain negative impact, it is necessary to stop the loss in time
    .
    Reflected in the price of volume purchases, that's it
    .
    A very clear logical line has been placed in front of you.
    After understanding where the road is ahead, I decided to go left or right
    .
    This is the reason for Guocai's contract renewal .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.